The emerging role of interleukin-41: a novel biomarker and therapeutic target in inflammation and immune-related diseases

Key Points

• Interleukin-41 acts as a novel biomarker for diagnosing inflammation, indicating its potential role in immune-related diseases.
• Evidence shows higher levels of interleukin-41 correlate with increased inflammation, suggesting it can guide treatment strategies.
• Assessment of interleukin-41 levels indicates its relevance in multiple immune-related conditions, highlighting its therapeutic potential.
• Further research on interleukin-41 could lead to new treatments for inflammation, emphasizing its importance in medical science.